| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021264854 |
| P356 | DOI | 10.1007/S11046-014-9774-0 |
| P698 | PubMed publication ID | 24969615 |
| P50 | author | Howard S | Q79224065 |
| P2093 | author name string | Susan Julie Howard | |
| P2860 | cites work | Aspergillus felis sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogs | Q21133504 |
| Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism | Q30853962 | ||
| Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus | Q30984430 | ||
| Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping | Q31065559 | ||
| Aspergillus calidoustus sp. nov., causative agent of human infections previously assigned to Aspergillus ustus. | Q31146944 | ||
| A polyphasic approach to the identification of ochratoxin A-producing black Aspergillus isolates from vineyards in Sicily | Q33358598 | ||
| Chronic invasive aspergillosis caused by Aspergillus viridinutans. | Q33628715 | ||
| Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis. | Q34042225 | ||
| Invasive aspergillosis caused by cryptic Aspergillus species: a report of two consecutive episodes in a patient with leukaemia. | Q34312487 | ||
| Cryptic species and azole resistance in the Aspergillus niger complex. | Q35270458 | ||
| Nonsporulating clinical isolate identified as Petromyces alliaceus (anamorph Aspergillus alliaceus) by morphological and sequence-based methods | Q35947376 | ||
| Isolation of Neosartorya pseudofischeri from blood: first hint of pulmonary Aspergillosis | Q36242300 | ||
| Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study). | Q36969672 | ||
| Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network | Q37374801 | ||
| Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. | Q37783285 | ||
| Emergence of Aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis | Q38026990 | ||
| Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification | Q42112017 | ||
| Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure | Q42555868 | ||
| Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri. | Q42586763 | ||
| Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. | Q42930104 | ||
| Secondary metabolite profiling, growth profiles and other tools for species recognition and important Aspergillus mycotoxins. | Q43087818 | ||
| Aspergillus viridinutans: an agent of adult chronic invasive aspergillosis | Q43427339 | ||
| In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus. | Q43505835 | ||
| Keratomycosis caused by Aspergillus viridinutans: an Aspergillus fumigatus-resembling mold presenting distinct clinical and antifungal susceptibility patterns | Q44002851 | ||
| Polyphasic characterization of fungal isolates from a published case of invasive aspergillosis reveals misidentification of Aspergillus felis as Aspergillus viridinutans | Q57568787 | ||
| Aspergillus alliaceusandAspergillus flavusco-infection in an acute myeloid leukemia patient | Q57651714 | ||
| Fatal outcome after heart transplantation caused by Aspergillus lentulus | Q84989536 | ||
| P433 | issue | 5-6 | |
| P921 | main subject | aspergillosis | Q259626 |
| cryptic species complex | Q765940 | ||
| P1104 | number of pages | 5 | |
| P304 | page(s) | 435-439 | |
| P577 | publication date | 2014-06-27 | |
| P1433 | published in | Mycopathologia | Q15763210 |
| P1476 | title | Multi-resistant aspergillosis due to cryptic species | |
| P478 | volume | 178 |
| Q85693074 | Advances against aspergillosis: biology, host response, diagnosis and treatment |
| Q46290816 | Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea. |
| Q39796605 | Antifungal susceptibility of 175 Aspergillus isolates from various clinical and environmental sources |
| Q50044352 | Antifungal susceptibility of the Aspergillus viridinutans complex: comparison of two in vitro methods |
| Q60045318 | Aspergillus pseudodeflectus: a new human pathogen in liver transplant patients |
| Q46440823 | Assessment of multi-contaminant exposure in a cancer treatment center: a 2-year monitoring of molds, mycotoxins, endotoxins, and glucans in bioaerosols. |
| Q46240270 | Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases: Comparison between Aspergillus fumigatus and non-fumigatus Aspergillus species |
| Q40424792 | DNA Barcoding Coupled with High Resolution Melting Analysis Enables Rapid and Accurate Distinction of Aspergillus species |
| Q90159929 | Development of multiplex real-time PCR for rapid identification and quantitative analysis of Aspergillus species |
| Q60921784 | Draft Genome Sequence of Azole-Resistant Aspergillus thermomutatus (Neosartorya pseudofischeri) Strain HMR-AF-39, Isolated from a Human Nasal Septum Abscess Aspirate |
| Q26748172 | Ecology of aspergillosis: insights into the pathogenic potency of Aspergillus fumigatus and some other Aspergillus species |
| Q28068091 | Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Aspergillus Fungi |
| Q90281858 | Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies |
| Q26771471 | Extrolites of Aspergillus fumigatus and Other Pathogenic Species in Aspergillus Section Fumigati |
| Q90589949 | From the Clinical Mycology Laboratory: New Species and Changes in Fungal Taxonomy and Nomenclature |
| Q35854893 | In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex. |
| Q39221749 | One-health pathogens in the Aspergillus viridinutans complex. |
| Q64239056 | Strategies for the management of invasive fungal infections due to filamentous fungi in high-risk hemato-oncological patients |
| Q50194392 | The Emerging Threat of Antifungal Resistance in Transplant Infectious Diseases |
| Q90047185 | Vitek® MS v3.0 System in the Identification of Filamentous Fungi |
Search more.